INCR
InterCure Ltd.- Healthcare
- Drug Manufacturers - Specialty & Generic
- $61M market cap
Forecast run · Sep 14, 2026Upside rank 1055 of 3,136
Model Signal
ForecastQ Daily Probabilities
44.0%
48.6%
22.1%
Analyst Consensus
Recommendation2.00/5 Buy
Last price$5.16
Price targetNo target
Analysts1
ForecastQ Portfolios
INCR is not in any ForecastQ portfolio today. The model scores it with every run; the names it picked are in Portfolios.
Company Profile
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.